Aadi Bioscience
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
17383 W Sunset Blvd Ste A250, Pacific Pa...Phone Number
(424) 744-8055Website
www.aadibio.comRevenue
$25.1 MillionStock Symbol
AADIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Aadi Bioscience
Aadi is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site.Explore more
Aadi Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aadi Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Aadi Bioscience has new funding data
Aadi Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aadi Bioscience
Check if Aadi Bioscience has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Aadi Bioscience recently announced quarterly report
Check out if Aadi Bioscience is spiking on competitors!
Product Launch: Get notified when Aadi Bioscience launches new products
Click to see if Aadi Bioscience had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Aadi Bioscience as Masked Content
Find 2 more new buyers
Compare Similar Companies to Aadi Bioscience
Compare insights from companies similar to Aadi Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aadi Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aadi Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aadi Bioscience.
Aadi Bioscience financials insights
Gather financial insights about Aadi Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$23M
2020
Debt
$150K
2022
Share Placement
$72.5M
2025
Share Placement
$100M
Aadi Bioscience Tech Stack
A closer look at the technologies used by Aadi Bioscience
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Aadi Bioscience News & Media
Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company
New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected to fund operations into 2028 enabling anticipated key clinical data readouts for its ADC assets Company shares to trade on...Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update
MORRISTOWN, N.J., March 14, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi") today announced that it will host a webcast to discuss fourth quarter and full-year 2024 financial results and provide recent corporate updates on Wednesday, March 19, 2025. These results will...Aadi Bioscience Announces Closing of $100 Million PIPE Financing
MORRISTOWN, N.J., March 4, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi"), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver advances in cancer treatment, today announced the closing of its previously...Aadi Bioscience Appoints David Dornan, PhD, as Chief Scientific Officer - PR Newswire
/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer (CSO). Dr....
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aadi Bioscience
Sign Up For FreeTo access detailed company insights
Aadi is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due t... Read More
